Cargando…
Ketamine in Bipolar Disorder: A Review
Bipolar disorder (BD) is a psychiatric illness associated with high morbidity, mortality and suicide rate. It has neuroprogressive course and a high rate of treatment resistance. Hence, there is an unquestionable need for new BD treatment strategies. Ketamine appears to have rapid antidepressive and...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670087/ https://www.ncbi.nlm.nih.gov/pubmed/33209026 http://dx.doi.org/10.2147/NDT.S282208 |
_version_ | 1783610668093538304 |
---|---|
author | Wilkowska, Alina Szałach, Łukasz Cubała, Wiesław J |
author_facet | Wilkowska, Alina Szałach, Łukasz Cubała, Wiesław J |
author_sort | Wilkowska, Alina |
collection | PubMed |
description | Bipolar disorder (BD) is a psychiatric illness associated with high morbidity, mortality and suicide rate. It has neuroprogressive course and a high rate of treatment resistance. Hence, there is an unquestionable need for new BD treatment strategies. Ketamine appears to have rapid antidepressive and antisuicidal effects. Since most of the available studies concern unipolar depression, here we present a novel insight arguing that ketamine might be a promising treatment for bipolar disorder. |
format | Online Article Text |
id | pubmed-7670087 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-76700872020-11-17 Ketamine in Bipolar Disorder: A Review Wilkowska, Alina Szałach, Łukasz Cubała, Wiesław J Neuropsychiatr Dis Treat Review Bipolar disorder (BD) is a psychiatric illness associated with high morbidity, mortality and suicide rate. It has neuroprogressive course and a high rate of treatment resistance. Hence, there is an unquestionable need for new BD treatment strategies. Ketamine appears to have rapid antidepressive and antisuicidal effects. Since most of the available studies concern unipolar depression, here we present a novel insight arguing that ketamine might be a promising treatment for bipolar disorder. Dove 2020-11-12 /pmc/articles/PMC7670087/ /pubmed/33209026 http://dx.doi.org/10.2147/NDT.S282208 Text en © 2020 Wilkowska et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Wilkowska, Alina Szałach, Łukasz Cubała, Wiesław J Ketamine in Bipolar Disorder: A Review |
title | Ketamine in Bipolar Disorder: A Review |
title_full | Ketamine in Bipolar Disorder: A Review |
title_fullStr | Ketamine in Bipolar Disorder: A Review |
title_full_unstemmed | Ketamine in Bipolar Disorder: A Review |
title_short | Ketamine in Bipolar Disorder: A Review |
title_sort | ketamine in bipolar disorder: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670087/ https://www.ncbi.nlm.nih.gov/pubmed/33209026 http://dx.doi.org/10.2147/NDT.S282208 |
work_keys_str_mv | AT wilkowskaalina ketamineinbipolardisorderareview AT szałachłukasz ketamineinbipolardisorderareview AT cubaławiesławj ketamineinbipolardisorderareview |